Inflammatory Cytokines in Heart Failure: Mediators and Markers

The Homeostatic Chemokine CCL21 Predicts Mortality and May Play a Pathogenic Role in Heart Failure

(2012) Arne Yndestad et al.   PLoS One

Fractalkine: a novel cardiac chemokine?

(2011) S. E. Altin et al.   CARDIOVASCULAR RESEARCH

Diastolic and Systolic Heart Failure Are Distinct Phenotypes Within the Heart Failure Spectrum

(2011) Barry A. Borlaug et al.   CIRCULATION

Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury

(2011) Masanori Kawaguchi et al.   CIRCULATION

The Emerging Role of Innate Immunity in the Heart and Vascular System

(2011) Douglas L. Mann   CIRCULATION RESEARCH

Osteoprotegerin Predicts Progression of Chronic Heart Failure: Results From CORONA

(2011) Thor Ueland et al.   Circulation-Heart Failure

When are pro-inflammatory cytokines SAFE in heart failure?

(2011) S. Lecour et al.   EUROPEAN HEART JOURNAL

Galectin-3 in heart failure: high levels are associated with all-cause mortality

(2011) Thor Ueland et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Osteoporosis: now and the future

(2011) Tilman D Rachner et al.   LANCET

Lack of Chemokine Signaling through CXCR5 Causes Increased Mortality, Ventricular Dilatation and Deranged Matrix during Cardiac Pressure Overload

(2011) Anne Waehre et al.   PLoS One

Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial

(2010) Ragnhild Røysland et al.   AMERICAN HEART JOURNAL

T Lymphocyte Regulation of Lysyl Oxidase in Diet-Induced Cardiac Fibrosis

(2010) Sherma Zibadi et al.   Cardiovascular Toxicology

Nonresolving Inflammation

(2010) Carl Nathan et al.   CELL

Pattern Recognition Receptors and Inflammation

(2010) Osamu Takeuchi et al.   CELL

Interleukin-17A Is Dispensable for Myocarditis but Essential for the Progression to Dilated Cardiomyopathy

(2010) G. Christian Baldeviano et al.   CIRCULATION RESEARCH

Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction

(2010) Dirk Westermann et al.   Circulation-Heart Failure

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

(2010) Dirk J. A. Lok et al.   Clinical Research in Cardiology

Interleukin 6 Mediates Myocardial Fibrosis, Concentric Hypertrophy, and Diastolic Dysfunction in Rats

(2010) Giselle C. Meléndez et al.   HYPERTENSION

Inhibition of matrix metalloproteinase activity prevents increases in myocardial tumor necrosis factor-α

(2010) David B. Murray et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice

(2009) Qianli Yu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

The Inflammasomes: Guardians of the Body

(2009) Fabio Martinon et al.   Annual Review of Immunology

Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

(2009) John J.V. McMurray et al.   CIRCULATION

Myocardial Ischemia/Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti–Toll-Like Receptor-2 Antibody

(2009) Fatih Arslan et al.   CIRCULATION

Increased Production of CXCL16 in Experimental and Clinical Heart Failure

(2009) Christen Peder Dahl et al.   Circulation-Heart Failure

Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure

(2009) Corinna Bergamini et al.   EUROPEAN JOURNAL OF HEART FAILURE

Galectin-3: a novel mediator of heart failure development and progression

(2009) Rudolf A. de Boer et al.   EUROPEAN JOURNAL OF HEART FAILURE

IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure

(2009) Weiwei Feng et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

The regulation of inflammation by galectin-3

(2009) Neil C. Henderson et al.   IMMUNOLOGICAL REVIEWS

TIMPs and cardiac remodeling: ‘Embracing the MMP-independent-side of the family’

(2009) Davy Vanhoutte et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

N-Terminal Pro–B-Type Natriuretic Peptide-Guided Treatment for Chronic Heart Failure

(2009) John G. Lainchbury et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects

(2008) P Fischer et al.   BRITISH JOURNAL OF PHARMACOLOGY

Ablation of Matrix Metalloproteinase-9 Increases Severity of Viral Myocarditis in Mice

(2008) Caroline Cheung et al.   CIRCULATION

Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure

(2008) Cathrine Husberg et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Impact of Oxypurinol in Patients With Symptomatic Heart Failure

(2008) Joshua M. Hare et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial

(2008) Guillermo Torre-Amione et al.   LANCET

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

(2008) GISSI-HF investigators   LANCET

Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure

(2007) Satoshi Suzuki et al.   AMERICAN HEART JOURNAL